DocDollars

Galderma Laboratories, L.P.

TX · United States · Reporting entity ID 100000010375

Total reported 2019–2025
$92.0M
#103 of 2,960 reporting companies — 0.1% of all reported industry payments
$86.1M in general payments across 373,184 records, plus $5.88M in research funding across 1,349 records.

How it breaks down

General payments $86,084,241
Research funding $5,880,357

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Galderma Laboratories, L.P. reported $92.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #103 of 2,960 reporting companies. 6% of that was research funding and 94% general payments such as consulting, speaking, food and travel. 373,184 general payment records and 1,349 research records were filed.

Common questions about Galderma Laboratories, L.P.

How much has Galderma Laboratories, L.P. paid US doctors?

Galderma Laboratories, L.P. reported $91,964,597 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $86,084,241 in general payments, $5,880,357 in research funding.

How does Galderma Laboratories, L.P. rank among drug and device companies?

It ranks #103 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Galderma Laboratories, L.P. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.